Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on Escherichia coli O157:H7.

J Mark Lawson1

  • 1Department of Medicine, Eastern Virginia Medical School, 5818 Harbourview Boulevard, Suite 240, Suffolk, VA 23435, USA. mlawson@giandliverspecialists.com

Current Gastroenterology Reports
|July 13, 2004
PubMed
Summary

Escherichia coli O157:H7 infections are a significant emerging threat, primarily transmitted via fecal-oral routes. This bacterium causes severe gastrointestinal illness and can lead to life-threatening complications, particularly in vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Management of Common Bile Duct Stones: Current Approaches and Evolving Endoscopic Strategies.

Current gastroenterology reports·2026
Same journal

Solitary Rectal Ulcer Syndrome Revisited: A Comprehensive Narrative Review.

Current gastroenterology reports·2026
Same journal

The Microbiome and Esophageal Disease: Where Are We Now?

Current gastroenterology reports·2026
Same journal

Fermented Durian Tempoyak as a Source of Probiotics for Colorectal Cancer Prevention through Gut Microbiome Modulation.

Current gastroenterology reports·2026
Same journal

A Practical Guide to Incorporating Novel Barrett's Screening/Surveillance Tools into Clinical Practice.

Current gastroenterology reports·2026
Same journal

The Role of Endoscopic Ultrasound in the Diagnosis and Management of Congenital Gastrointestinal and Pancreaticobiliary Conditions.

Current gastroenterology reports·2026

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Escherichia coli O157:H7 is an emerging infectious disease prominent in industrialized nations since the 1980s.
  • Associated with significant morbidity and mortality, it is commonly found in cattle and transmitted via fecal-oral routes.
  • The pathogen's resilience allows environmental survival for months, facilitating cross-contamination.

Purpose of the Study:

  • To review the clinical significance and characteristics of Escherichia coli O157:H7 infections.
  • To highlight transmission routes, clinical presentation, and pathological findings.
  • To discuss potential complications and current understanding of treatment efficacy.

Main Methods:

  • Literature review of clinical and epidemiological data on Escherichia coli O157:H7.
  • Analysis of typical clinical presentations and biopsy findings.
  • Evaluation of associated toxins and complications, including hemolytic uremic syndrome.

Main Results:

  • Classic presentation includes watery diarrhea progressing to bloody diarrhea, often without significant fever.
  • Biopsy findings resemble ischemic colitis, with superficial mucosal inflammation and hemorrhage.
  • Shiga-like toxins produced by E. coli O157:H7 can cause thrombotic complications like hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP).

Conclusions:

  • Escherichia coli O157:H7 poses a considerable public health risk, especially to the very young and elderly.
  • Antibiotic treatment's role in increasing complication risk remains inconclusive, with outcomes influenced by multiple factors.
  • Understanding transmission and pathogenesis is crucial for managing this significant infectious disease.

Related Experiment Videos